04.16.07: Biotechnology Report
A roundtable forum, 3 analysts and top management from 20 firms examine the Biotechnology sector in this 104 page report from The Wall Street Transcript.

  1. Roundtable Forum: Kevin DeGeeter, H.C. Wainwright & Co., Edward H. Nash, Stifel, Nicolaus & Co.

  2. Therapeutic-Focused Biotechnology Companies: Biren Amin, Stanford Group Company

  3. Development-Stage Biopharmaceutical Companies: Brian Rye, Janney Montgomery Scott

  4. Micro-Cap Biotechnology Companies: Rahul Jasuja, MDB Capital Group

  5. Off the Record: Off the Record asks company leadership which management teams in their sector they most respect for their ability to execute and generate shareholder value.

  6. CEO Interviews (average 2,500 words): Top management from 20 sector firms examine the outlook for their firm and sector. Firms interviewed include: Aradigm Corp., Cyclacel Pharmaceuticals, Dyax Corp., GeneThera, Haemacure Corp., Hana Biosciences, Hemispherx BioPharma, Immtech Pharmaceuticals, MedMira, Microbix Biosystems, NeoStem, Nutra Pharma, Opexa Therapeutics, Pharmacopeia Drug Discovery, Pluristem Life Systems, Sangamo Biosciences, Spectral Diagnostics, Synthetech, Transgenomic and Vitro Diagnostics.

    Topics covered: Valuations in small cap Biotech - Generic biologics - Reimbursement - M&A expectations - FDA environment - Pipeline projects - Oncology space - Special Protocol Assessment (SPA) process - Patent expirations - Therapeutic drug companies - Toll-like receptor (TLR) space

    Companies covered: Amgen (AMGN), Genentech (DNA), LAB International (LAB:TSX), Progenics (PGNX), Panacos (PANC), Gilead (GILD), Genzyme Corp. (GENZ), Novartis (NVS), Momenta Pharmaceuticals (MNTA), Cubist Pharmaceuticals (CBST), Sepracor (SEPR), Medarex (MEDX), AEterna Zentaris (AEZS), Palatin Technologies (PTN), Idera Pharmaceuticals (IDP) and Emisphere Technologies (EMIS).
    ORDER THIS REPORT NOW! ONLY $175
    The report will be mailed first class. For fedex delivery, specify in the report details section and either include your fedex number or we will add $15 delivery charge. All sales are final.  Questions, call (212) 952-7433, or email us

    For immediate access online - click here to gain a password.  

    Report details:  
    Your Name:  
    		 Company: 
    Address: 
    		 City: 
    State/Province:
    		 ZIP/Postal Code:
           		 Country:
    Phone:
    		 E-Mail:

    BILLING INFORMATION
    Credit Card
    		 Expiration Month/Year:
    Credit Card Number: 

     This Issue costs $175 - and is non-returnable.   

    The Wall Street Transcript does not endorse the views of any interviewee nor does it make stock recommendations.

 

Investors and Industry Execs.

The Wall Street Transcript has been used by investors and industry executives for 40 years as a unique tool for company and industry research.

TWST's roundtable panels and analyst interviews provide a sector perspective from Wall Street's best. 

Money manager interviews provide the view from the buy-side.

CEO interviews with hundreds of companies from the major sectors gives the company perspective right from the top.


Subscribe to a unique research tool for investors and industry executives. Call (212) 952 7433 or click here.

Sincerely,

Andrew Pickup
Publisher
HOME PRODUCTS SUBSCRIBE ABOUT ARCHIVE HOTLINE CONTACT EUROPE